Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

YMTX

Yumanity Therapeutics (YMTX)

Yumanity Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:YMTX
DatumZeitQuelleÜberschriftSymbolFirma
16/12/202220h58Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:YMTXYumanity Therapeutics Inc
16/12/202216h38Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:YMTXYumanity Therapeutics Inc
15/12/202212h43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMTXYumanity Therapeutics Inc
13/12/202222h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMTXYumanity Therapeutics Inc
06/12/202222h56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMTXYumanity Therapeutics Inc
06/12/202222h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMTXYumanity Therapeutics Inc
06/12/202222h52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMTXYumanity Therapeutics Inc
06/12/202222h05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:YMTXYumanity Therapeutics Inc
06/12/202222h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMTXYumanity Therapeutics Inc
05/12/202215h29Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:YMTXYumanity Therapeutics Inc
05/12/202215h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMTXYumanity Therapeutics Inc
05/12/202213h30GlobeNewswire Inc.Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with KinetaNASDAQ:YMTXYumanity Therapeutics Inc
01/12/202222h05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:YMTXYumanity Therapeutics Inc
15/11/202222h04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:YMTXYumanity Therapeutics Inc
15/11/202222h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMTXYumanity Therapeutics Inc
14/11/202214h45Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:YMTXYumanity Therapeutics Inc
14/11/202214h38Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMTXYumanity Therapeutics Inc
14/11/202214h16GlobeNewswire Inc.Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMTXYumanity Therapeutics Inc
14/11/202212h09Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:YMTXYumanity Therapeutics Inc
10/11/202222h27Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:YMTXYumanity Therapeutics Inc
10/11/202222h15GlobeNewswire Inc.Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.NASDAQ:YMTXYumanity Therapeutics Inc
04/11/202221h53Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:YMTXYumanity Therapeutics Inc
27/10/202213h16Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:YMTXYumanity Therapeutics Inc
27/10/202213h14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMTXYumanity Therapeutics Inc
26/10/202223h19Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:YMTXYumanity Therapeutics Inc
26/10/202223h18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMTXYumanity Therapeutics Inc
26/10/202223h09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMTXYumanity Therapeutics Inc
24/10/202215h17Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:YMTXYumanity Therapeutics Inc
24/10/202214h02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:YMTXYumanity Therapeutics Inc
24/10/202213h59Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMTXYumanity Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:YMTX

Kürzlich von Ihnen besucht

Delayed Upgrade Clock